✦ LIBER ✦

The STAR results: choosing between raloxifene and tamoxifen for preventing invasive breast cancer in postmenopausal women

✍ Scribed by Jame Abraham

Book ID: 118628643
Publisher: Frontline Medical Communications, Inc.
Year: 2006
Tongue: English
Weight: 85 KB
Volume: 3
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70927-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale for using raloxifene to preven

Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women

✍ Wen-Ling Lee; Hsiang-Tai Chao; Ming-Huei Cheng; Peng-Hui Wang 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Arzoxifene for prevention of fractures a

Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women

✍ Steven R Cummings; Michael McClung; Jean-Yves Reginster; David Cox; Bruce Mitlak 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 97 KB

## Abstract Arzoxifene is a selective estrogen receptor modulator (SERM) that has been shown to be more potent in preclinical testing than currently available agents. Its effects on clinical outcomes are not known. In a randomized, blinded trial, women aged 60 to 85 years with osteoporosis, defined

Gynecologic conditions in participants i

Gynecologic conditions in participants in the NSABP breast cancer prevention study of tamoxifen and raloxifene (STAR)

✍ Carolyn D. Runowicz; Joseph P. Costantino; D. Lawrence Wickerham; Reena S. Cecch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Women’s interest in taking tamoxifen and

Women’s interest in taking tamoxifen and raloxifene for breast cancer prevention: response to a tailored decision aid

✍ Angela Fagerlin; Amanda J. Dillard; Dylan M. Smith; Brian J. Zikmund-Fisher; Ros 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 300 KB

Identifying cost-effective treatment wit

Identifying cost-effective treatment with raloxifene in postmenopausal women using risk algorithms for fractures and invasive breast cancer

✍ M. Ivergård; O. Ström; F. Borgström; R.T. Burge; A.N.A. Tosteson; J. Kanis 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 625 KB

1–58 Patient-Reported Symptoms and Quali

1–58 Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB